Now Reading
U.S. Firm Pursues FDA-Registered Trial for Pot-Based Therapy for Parkinson’s Disease

U.S. Firm Pursues FDA-Registered Trial for Pot-Based Therapy for Parkinson’s Disease

Dina Al-Shibeeb
Screen Shot 2018 04 10 at 1.50.45 PM 20x16 - U.S. Firm Pursues FDA-Registered Trial for Pot-Based Therapy for Parkinson’s Disease

Based in Las Vegas, GB Sciences, Inc. (OTCQB: GBLX) is pursuing a federally-registered trial in humans by using cannabis-based therapies for the treatment of early to moderate Parkinson’s disease.

GB Sciences, which deals with cannabis production as well as biopharmaceutical research, is eying a federal route for its initial trial to fasten the process. 

GB Sciences said in a statement: 

Performing an FDA-Registered clinical trial, instead of a Nevada-based pilot trial as reported earlier, also translates to quicker entry into international markets with harmonized regulatory standards.” 

Federally, medical marijuana is not seen as a real alternative as that of conventional, pharmaceutical medicine. However, pursuing a trial registered by the Food and Drug Administration (FDA), the federal agency of the United States Department of Health and Human Services, shows how the growing trend of marijuana legalization is gaining strong momentum.

The company acknowledges that it will be “more difficult” to register the First-in-Human trial with the FDA at the time being but it said: “The longer-term benefits for the patients and GB shareholders should be great.”

As the world opens up to marijuana’s benefits, more universities and institutes are kick-starting research to explore the green herb’s medicinal value.

See Also
woman with blue eyes and black hair 3693881 scaled e1591820967346 180x180 - U.S. Firm Pursues FDA-Registered Trial for Pot-Based Therapy for Parkinson’s Disease

In late March, the first U.S. publicly traded cannabis company Medical Marijuana, Inc. has agreed to help a Brazilian university research if cannabis can help Parkinson’s patients.

For more details about the GB Sciences’ clinical trial, click HERE.

[share-btn]
Comments
View Comments (0)

Leave a Reply

Scroll To Top